Role of immunologic factors and cyclooxygenase 2 in persistent postinfective enteric muscle dysfunction in mice

G Barbara1, R De Giorgio, Y Deng

  • 1Intestinal Disease Research Program and Division of Gastroenterology, Health Sciences Center, McMaster University, Hamilton, Ontario, Canada.

Gastroenterology
|May 29, 2001
PubMed
Abstract

Insights

Persistent smooth muscle hypercontractility after enteric infection is linked to cyclooxygenase-2 (COX-2) activation. This study in mice reveals COX-2 in the muscularis externa contributes to chronic abdominal symptoms post-infection.

Area of Science:

  • Gastroenterology
  • Immunology
  • Pharmacology

Background:

  • Chronic abdominal symptoms can follow acute enteric infections.
  • The underlying mechanisms of persistent smooth muscle hypercontractility are not fully understood.

Purpose of the Study:

  • To investigate the cellular mechanisms of sustained smooth muscle hypercontractility after acute enteric infection in a mouse model.
  • To identify the role of cyclooxygenase-2 (COX-2) in post-infectious gastrointestinal dysfunction.

Main Methods:

  • Mice were infected with Trichinella spiralis and studied 4 weeks post-infection.
  • Isometric tension, cytokine expression (interleukins 4, 5, 13), COX-2 mRNA and protein, and prostaglandin E2 levels were assessed in the muscularis externa.
  • Studies included euthymic and athymic mice, with and without corticosteroid or COX inhibitor treatment.

Main Results:

  • Muscle hypercontractility was observed in infected euthymic mice, attenuated in athymic mice or those treated with steroids.
  • COX-2 expression and enzymatic activity remained elevated in the muscularis externa 28 days post-infection.
  • Inhibition of COX-2 in vitro reduced sustained tension generation.

Conclusions:

  • Cyclooxygenase-2 (COX-2) activation in resident muscularis externa cells contributes to persistent smooth muscle hypercontractility after enteric infection.
  • This COX-2 mediated hypercontractility may underlie chronic abdominal symptoms post-infection.

Related Concept Videos

Peptic Ulcer Disease II: Pathophysiology01:24

Peptic Ulcer Disease II: Pathophysiology

Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...